Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part I. Epidemiology, pathogenesis, clinicopathological features, and prognosis.
Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA.
Drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms. Part II diagnosis and management.
Wei BM, Fox LP, Kaffenberger BH, Korman AM, Micheletti RG, Mostaghimi A, Noe MH, Rosenbach M, Shinkai K, Kwah JH, Phillips EJ, Bolognia JL, Damsky W, Nelson CA.
Guidelines for the management of drug-induced hypersensitivity syndrome 2023.
Mizukawa Y, Hama N, Niihara H, Miyagawa F, Hashizume H, Tohyama M, Takahashi H, Watanabe H, Ohyama M, Yamaguchi Y, Kawamura T, Nomura T, Kabashima K, Sueki H, Morita E, Abe R, Asada H.
J Dermatol. 2025 Mar;52(3):e189-e209. doi: 10.1111/1346-8138.17609. Epub 2025 Feb 3.
PMID:39895539
Drug-induced hypersensitivity syndrome due to phenytoin: Case report and review of the literature.
Wang L, Zhang J, Wang X, Xu Y.
Medicine (Baltimore). 2024 Sep 27;103(39):e39715. doi: 10.1097/MD.0000000000039715.
PMID:39331866
Multiple Drug Hypersensitivity Syndrome in a Large Database.